Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Montejo, Angel L., Rub�n de Alarc�n, Nieves Prieto, Jos� M� Acosta, B�rbara Buch, and Laura Montejo. "Management strategies for antipsychotic-related sexual dysfunction: A clinical approach." Journal of Clinical Medicine 10, no. 2 (2021): 308. |
|
Khoury, Bassam, Tania Lecomte, Ginette Comtois, and Luc Nicole. "Third?wave strategies for emotion regulation in early psychosis: A pilot study." Early intervention in psychiatry 9, no. 1 (2015): 76-83. |
|
Chue, Pierre S., and Arno G. Siraki. "Antipsychotic drugs." In Side Effects of Drugs Annual, vol. 39, pp. 65-90. Elsevier, 2017. |
|
Deng, Gary. "Integrative medicine therapies for pain management in cancer patients." Cancer Journal (Sudbury, Mass.) 25, no. 5 (2019): 343. |
|
Wang, Shentong, and Mark Agius. "The use of music therapy in the treatment of mental illness and the enhancement of societal wellbeing." Psychiatria Danubina 30, no. Suppl 7 (2018): 595-600. |
|
CANTARIDA, CIBERINDEX. "An�lisis de la aplicaci�n intramuscular en pacientes que realizan tratamiento con Paliperidona de Liberaci�n Prolongada Mensual o Trimestral: Diferencias de G�nero." Presencia 16 (2020): e12763. |
|
Kimhy, David, Melanie M. Wall, Marie C. Hansen, Julia Vakhrusheva, C. Jean Choi, Philippe Delespaul, Nicholas Tarrier, Richard P. Sloan, and Dolores Malaspina. "Autonomic regulation and auditory hallucinations in individuals with schizophrenia: an experience sampling study." Schizophrenia Bulletin 43, no. 4 (2017): 754-763. |
|
Khoury, Bassam, Tania Lecomte, Brandon A. Gaudiano, and Karine Paquin. "Mindfulness interventions for psychosis: a meta-analysis." Schizophrenia research 150, no. 1 (2013): 176-184. |
|
Del Casale, A., M. C. Rossi-Espagnet, A. Napolitano, M. Lucignani, L. Bonanni, G. D. Kotzalidis, A. Buscajoni et al. "Cerebral cortical thickness and gyrification changes in first-episode psychoses and multi-episode schizophrenia." Archives Italiennes de Biologie 159, no. 1 (2021): 3-20. |
|
Watanabe, Takafumi, and Atsurou Yamada. "Effects of Discontinuation of Paliperidone Long-Acting Injectable After Switching from Risperidone Long-Acting Injectable Switching." Psychopharmacology bulletin 46, no. 2 (2016): 42. |
|
Gonz�lez Rodr�guez, Alexandre, Rosa Catal�n, Rafael Penad�s Rubio, Clemente Garc�a Rizo, Miquel Bioque Alc�zar, Eduard Parellada Rod�n, and Miquel Bernardo Arroyo. "Profile of paliperidone palmitate once-monthly-long-acting in the management of schizophrenia: long-term safety, efficacy and patient acceptability-a review." Patient Preference And Adherence, 2015, vol. 9, p. 695-706 (2015). |
|
Zuliani, Riccardo, Giuseppe Delvecchio, Carolina Bonivento, Giulia Cattarinussi, Cinzia Perlini, Marcella Bellani, Veronica Marinelli et al. "Increased gyrification in schizophrenia and non affective first episode of psychosis." Schizophrenia research 193 (2018): 269-275. |
|
Neilson, E., C. Bois, T-K. Clarke, L. Hall, E. C. Johnstone, D. G. C. Owens, H. C. Whalley, A. M. McIntosh, and S. M. Lawrie. "Polygenic risk for schizophrenia, transition and cortical gyrification: a high-risk study." Psychological medicine 48, no. 9 (2018): 1532-1539. |
|
Spalthoff, Robert, Christian Gaser, and Igor Nenadi?. "Altered gyrification in schizophrenia and its relation to other morphometric markers." Schizophrenia research 202 (2018): 195-202. |
|
Chua, Wan Lian LC, Hristo S. Grigorov, and John Hiley. "Oestrogen (adjunct) versus placebo for women with schizophrenia." Cochrane Database of Systematic Reviews 6 (2016). |
|
Lee, KyuYoung. "The long-acting injectable antipsychotics in clinical practice." Journal of Korean Neuropsychiatric Association 58, no. 1 (2019): 29-37. |
|
Rocha, Evita, Andrei Novac, Daniel Kirsten, Jiwon Shin, Diana Totoiu, and Robert G. Bota. "Psychosis, Catatonia and Post-psychosis PTSD." Journal of Advances in Medicine and Medical Research (2016): 1-5. |
|
Valiente-G�mez, Alicia, Nuria Pujol, Ana Moreno-Alc�zar, Joaquim Radua, Eila Monteagudo-Gimeno, Itxaso Gardoki-Souto, Bridget Hogg et al. "A Multicenter Phase II RCT to Compare the Effectiveness of EMDR Versus TAU in Patients With a First-Episode Psychosis and Psychological Trauma: A Protocol Design." Frontiers in psychiatry 10 (2020): 1023. |
|
Procyshyn, Ric M., Joel W. Lamoure, Martin A. Katzman, Pamela L. Skinner, and Stephen E. Sherman. "Need for bioequivalence standards that reflect the clinical importance of the complex pharmacokinetics of paliperidone palmitate long-acting injectable suspension." Journal of Pharmacy & Pharmaceutical Sciences 22 (2019): 548-566. |
|
du Montcel, Chlo� Tezenas, C�lia Kowal, Audrey Leherle, Soraya Kabbaj, Ariel Frajerman, Emmanuel Le Guen, Nora Hamdani et al. "Isolement et contention m�canique dans les soins psychiatriques: modalit�s de prescription, prise en charge et surveillance." La Presse M�dicale 47, no. 4 (2018): 349-362. |
|